Search for: "Ely v. State"
Results 641 - 660
of 1,090
Sorted by Relevance
|
Sort by Date
15 Apr 2010, 6:22 am
In KSR v. [read post]
10 Feb 2024, 4:24 am
Photo: Eli DukeLack of genuine useMoving to genuine use, the crux of Noah Clothing's argument related to the fact that the majority of the pictures shown in Mr Noah's evidence seeking to show genuine use of the Mark, showed goods bearing the Second Mark instead. [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v Eli Lilly… [read post]
20 Sep 2014, 6:38 am
Wells promised that while he could not personally attend a two-day pre-trial hearing in the case of United States v. [read post]
9 May 2017, 4:42 am
Subsequently, the CJEU held in Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc [EU: C:2013:835] that Article 3(a) must be interpreted as meaning that it was not necessary for the active ingredient to be identified in the claim by means of a structural formula. [read post]
9 Jun 2014, 10:08 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
19 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
18 Nov 2009, 4:57 am
Eli Lilly & Co. [read post]
18 Nov 2009, 4:57 am
Eli Lilly & Co. [read post]
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market… [read post]
18 Nov 2009, 4:57 am
Eli Lilly & Co. [read post]
6 Jul 2010, 6:03 pm
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market… [read post]
26 Jun 2015, 5:58 pm
He was co-counsel on an amicus brief in support of the petitioners in Obergefell v. [read post]
15 May 2017, 12:00 am
Eli Lilly and Company – United States District Court – Eastern District of Texas – March 17th, 2017) is one of patent infringement. [read post]
15 May 2017, 12:00 am
Eli Lilly and Company – United States District Court – Eastern District of Texas – March 17th, 2017) is one of patent infringement. [read post]
10 Sep 2018, 1:20 am
’“ 3) International Investment Arbitration, the European Patent Office, and the Future Unified Patent Court by Thomas Musmann “Since the Eli Lilly v. [read post]
10 Sep 2018, 1:25 am
’“ 3) International Investment Arbitration, the European Patent Office, and the Future Unified Patent Court by Thomas Musmann “Since the Eli Lilly v. [read post]
7 Aug 2008, 12:49 pm
Eli Lilly & Co., 751 P.2d 923 (Cal. 1988). [read post]
21 May 2018, 7:22 pm
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
2 Jun 2014, 4:43 am
Louisiana joined the fray late in Sergeants Benevolent Association Health & Welfare Fund v. [read post]
